1. Alginate Encapsulant Incorporating CXCL12 Supports Long‐Term Allo‐ and Xenoislet Transplantation Without Systemic Immune Suppression. Issue 3 (March 2015) Authors: Chen, T.; Yuan, J.; Duncanson, S.; Hibert, M. L.; Kodish, B. C.; Mylavaganam, G.; Maker, M.; Li, H.; Sremac, M.; Santosuosso, M.; Forbes, B.; Kashiwagi, S.; Cao, J.; Lei, J.; Thomas, M.; Hartono, C.; Sachs, D.; Markmann, J.; Sambanis, A.; Poznansky, M. C. Journal: American journal of transplantation Issue: Volume 15:Issue 3(2015:Mar.) Page Start: 618 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Polyfunctionality of the CXCR4/CXCL12 axis in health and disease: Implications for therapeutic interventions in cancer and immune‐mediated diseases. Issue 4 (14th March 2021) Authors: Britton, C.; Poznansky, M. C.; Reeves, P. Journal: FASEB journal Issue: Volume 35:Issue 4(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗